Our mission

Mission of this society is to promote health benefits of phytonutrients.

   Epigallocatechin-3-gallate, or EGCG, is a polyphenolic compound present in green tea, and tea is second only to water as a major component of fluid intake worldwide.1 EGCG may offer neuroprotective effects for people with Alzheimer’s disease,2 and may help stop the proliferation of cancerous cells in the lungs.3 Further, a recent meta-analysis on breast cancer showed the combined results of green tea consumption from four studies showed a reduced risk of breast cancer for the highest versus lowest intake groups.4 The PI for EGCG was found to be 0.6 mg/day. Among all adults 19 years and older, 37% meet this PI, which means 63% fall short. It has been shown that the percentage of Americans, by age group, who has a gap in their EGCG consumption.

1. Khan N, Mukhtar H, Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008;269:269-80.
2. Kim CY, Lee C, Park GH, Jang JH. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity Arch Pharm Res 2009;32:869-81.
3. Milligan SA, Burke P, Coleman DT et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009;15:4885-94.
4. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006;27:1301-09